Significance: The oxidative process of disulfide-bond formation is essential for the folding of most secretory and membrane proteins in the endoplasmic reticulum (ER). It is driven by electron relay pathways that transfer two electrons derived from the fusion of two adjacent cysteinyl side chains onto various types of chemical oxidants. The conserved, ER-resident endoplasmic oxidoreductin 1 (Ero1) sulfhydryl oxidases that reduce molecular oxygen to generate an active-site disulfide represent one of these pathways. In mammals, two family members exist, Ero1a and Ero1b. Recent Advances: The two mammalian Ero1 enzymes differ in transcriptional and posttranslational regulation, tissue distribution, and catalytic turnover. A specific protein-protein interaction between either isoform and protein disulfide isomerase (PDI) facilitates the propagation of disulfides from Ero1 via PDI to nascent polypeptides, and inbuilt oxidative shutdown mechanisms in Ero1a and Ero1b prevent excessive oxidation of PDI. Critical Issues: Besides disulfide-bond generation, Ero1a also regulates calcium release from the ER and the secretion of disulfide-linked oligomers through its reversible association with the chaperone ERp44. This review explores the functional repertoire and possible redundancy of mammalian Ero1 enzymes. Future Directions: Systematic analyses of different knockout mouse models will be the most promising strategy to shed new light on unique and tissue-specific roles of Ero1a and Ero1b. Moreover, in-depth characterization of the known physical interactions of Ero1 with peroxidases and PDI family members will help broaden our functional and mechanistic understanding of Ero1 enzymes.
Since the resolution of mismatched substrate disulfides by reduced PDIs is a fundamental component of oxidative protein folding, an unregulated (hyper-) oxidation of PDI by Ero1p would be undesirable. Thus, a redox-sensitive shutdown mechanism represented by noncatalytic, intramolecular disulfide bonds effectively impairs Ero1p activity (27, 48) . As the oxidation state of these cysteine pairs is controlled by the ER redox poise, a regulatory feedback loop ensues in which Ero1p is solely active when new disulfides are required (48) . Taken together, many of the conserved features of Ero1 sulfhydryl oxidases including their fold, mechanism of action, physiological relevance, substrate specificity, and the principle of their tunable activation status have been unraveled in experiments with the yeast enzyme.
What Yeast Has Failed to Teach Us
Orthologs of Ero1p exist in all eukaryotes (8) . Mammalian genomes harbor two Ero1-like genes, ERO1L and ERO1LB, which encode Ero1a and Ero1b, respectively (14, 42) , and will be the subject of this review. Interestingly, the study of Ero1a and Ero1b has not only unveiled many parallels to the yeast enzyme, but also a number of important differences. Most prominent among these, the mammalian Ero1 genes appear to be nonessential, as evidenced by the viability of mice carrying mutated copies of both ERO1L and ERO1LB (55) . The mutated genes feature an intronic ''gene trapping'' insertion containing a strong viral splice acceptor. As a consequence, the vast majority of mRNAs derived from the ERO1L/ERO1LB loci will give rise to nonfunctional, truncated proteins.
Lipopolysaccharide-activated spleen cells (LPS blasts) isolated from the mutant mice are nearly indistinguishable from their wild-type counterparts with regard to the efficiency of The thiol-disulfide exchange reaction. Cartoon depicting the mechanism of thiol-disulfide exchange between a reduced (SH) and a disulfide-linked (S-S) cysteine pair (e.g., residing on two separate proteins). Upon deprotonation of one of the cysteinyl thiol groups, the resulting thiolate anion nucleophilically attacks one of the disulfide-bound sulfur atoms, leading to the formation of a mixed-disulfide complex. Deprotonation of and nucleophilic attack by the second thiol group then prompts the formerly reduced pair of cysteines to form a disulfide bond. In the course of this redox reaction, two electrons are transferred from the reductant to the oxidant in exchange of two ''oxidizing equivalents.'' A disulfide bond is generated by the transfer of two oxidizing equivalents from the flavin adenine dinucleotide cofactor (shown as three black rings embedded between the four Ero1 core a-helices, drawn as dark gray cylinders) to the inner-active-site cysteine pair in Ero1 (step a). After the intramolecular thiol-disulfide exchange reaction (see Fig. 1 ) between inner and outer active site of Ero1 (step b), the disulfide bond is transferred from the outer active site (located within a flexible loop region in Ero1, depicted by a sinuous black curve) to one of the two di-cysteine active sites in PDI (step c). As a consequence, PDI is capable of introducing disulfide bonds into nascent polypeptides (dubbed ''substrate'') through thiol-disulfide exchange (step d). Arrows denote the flow of two oxidizing equivalents; cysteine pairs are depicted only by their sulfur atoms (S); the four thioredoxin-like domains in PDI are represented by gray circles. Ero1, endoplasmic oxidoreductin 1; PDI, protein disulfide isomerase.
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oxidative folding of immunoglobulin M (IgM) (55, 56) . With one known exception (the oxidative folding of proinsulin in the b-cells of the pancreas, discussed further below), it is therefore reasonable to assume that the overall pace of disulfide-bond formation is not severely compromised in ERO1L/ERO1LB mutant mice and does not phenocopy the fatal situation in Ero1p-deficient yeast cells. These observations can be explained by alternative mechanisms for de novo disulfide-bond generation in the mammalian ER (13) and/or by incomplete gene trapping, which would allow the low-level synthesis of operational Ero1 molecules. Indeed, residual amounts of Ero1b were detected on mRNA level in cardiomyocytes (16) and on protein level in pancreatic tissue and LPS blasts from Ero1 double mutant mice (55) . In all cell types studied so far, only a minor portion of Ero1a and, presumably, Ero1b is maintained in an active form (6, 11, 16 ) (see also below). Consequently, when shifted to increased activity through redox regulation, the residual levels of Ero1b in ERO1L/ERO1LB compound mutant mice might actually suffice to support disulfide-bond formation. Along the same lines, yeast cells can proliferate in the presence of very low amounts of Ero1p. Sufficient levels of Ero1p to allow for growth of an ero1-null strain can be provided by a plasmid encoding ERO1 under the control of a galactoseinducible promoter even when cells are grown in glucose (where the promoter is largely repressed) (Carolyn S. Sevier, pers. comm.). It is therefore important to consider that the designation of ERO1L/ERO1LB mutant mice as ''knockout animals'' can provoke an underestimation of the functional significance of Ero1 enzymes in mammals. Interestingly, the high proliferation rate of immortalized mouse embryonic fibroblasts is profoundly affected by the ERO1L/ERO1LB compound mutation (Ester Zito, David Ron, and Christian Appenzeller-Herzog, unpublished observations), suggesting that under in vitro conditions, normal levels of Ero1 enzymes are required for optimal cell growth. On the other hand, flies homozygous for a nonsense allele of their single ERO1L gene develop almost normally (49) , which strongly suggests the existence of ERO1L-independent pathways for disulfide-bond formation.
In addition, while both Ero1p and Ero1a (and, most likely, Ero1b) are soluble ER proteins, which are peripherally membrane-associated (14, 20, 42) , only Ero1p possesses a C-terminal membrane-targeting domain (43) . Further differences between Ero1p and the mammalian Ero1 enzymes include a distinct set of regulatory disulfide bonds for the shutdown of oxidase activity and different mechanisms of substrate recognition and oxidation. These issues will be covered in subsequent sections. ) and the cysteine connectivity of Ero1b is speculative at present (see main text for details). Cysteines of structural or unknown function (light gray) are connected with dotted brackets in case of disulfide-bond connection. Question marks denote that no conclusive redox state has been demonstrated, yet. Ero1p possesses an additional C-terminal domain that is responsible for its tethering to the membrane (dark gray box). For more detailed information regarding redox-state-dependent changes in the cysteine connectivity refer to the main text.
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forms a ''nonactive-site'' disulfide with Cys 104 in the shut-off state of Ero1a (10) . Like Cys 131 , Cys 104 has no equivalent in Ero1p.
The identification of these new types of regulatory disulfide, which are likely to be present in Ero1b, too (53) , has implications for the redox-driven mechanisms of enzyme (in)activation. Thus, in an oxidizing ER environment when reduced substrates for Ero1a are scarce, newly produced disulfide bonds arising from the inner active site will be ''stored'' as Cys 94 As to the reactivation under reducing conditions, the situation is less straightforward. Two electrons are required to break either of the two regulatory disulfide bonds, before the shuttle disulfide can be reformed through nucleophilic attack. The finding that the concentration of reduced PDI in the ER influences the extent of Cys 94 -Cys 131 formation suggests PDI as the reductant (6). However, PDI has proven to be an ineffective activator of Ero1a in a reconstituted reaction (9, 10, 15, 52) . In keeping with the predominantly inactive state of Ero1a in the ER (6, 11, 16) , this relative resistance of Ero1a toward PDI-mediated reduction could be a critical determinant of ER redox control rather than a manifestation of its poor catalytic proficiency. Indeed, when the thiol load of the ER is maximized by treatment with a strong reducing agent, the Ero1a-dependent re-formation of disulfides is exceptionally fast upon washout of the reductant (7). These findings are consistent with the concept that Ero1a is an environmentdependent sulfhydryl oxidase, the activity of which is governed by the redox state of its own substrate(s).
In contrast to the aforementioned disulfide bonds, the longrange disulfide, which is conserved in all Ero1 orthologs, does not involve any active-site cysteines (Fig. 3) . Two alternative views exist on the role of this disulfide during catalysis. Based on the finding that purified Ero1a C85A-C104A-C131A-C391A-although well-folded-is less active in an oxidase assay than Ero1a C104A-C131A (9), one opinion holds that Cys 85 -Cys 391 must be intact for efficient substrate oxidation. The second view, which we tend to favor, suggests a rearrangement of this disulfide during enzyme activation. Thus, an as yet unidentified cysteinyl thiolate anion might attack, for example, Cys 85 and thereby free Cys 391 to create a new short-range disulfide in Ero1a that facilitates the communication between inner and outer active site. It can also be speculated that the presumed isomerization reaction is not readily triggered through intramolecular attack, but instead catalyzed by a thiol-disulfide isomerase such as ERp44 or another PDI that could initially resolve the long-range disulfide (for discussion of mixed-disulfide interactions of Ero1, see below). In potential support of this second view, activated Ero1a (10) and Ero1b (53) virtually co-migrate with the fully reduced forms on nonreducing gels. In addition, presumably catalytic mixed-disulfide complexes between Ero1a or Ero1b and PDI trapped in living cells after treatment with a reductant display markedly decreased gel mobility-indicative of long-range disulfide resolution-as compared with the complexes trapped at steady state (7) . Intriguingly, the crystal structure of a hyperactive Ero1a C104A-C131A mutant, which still harbors Cys 85 -Cys 391 , does not reveal any obvious pathway for O 2 to reach the protein-embedded FAD moiety (29) . We speculate that structural flexibility upon disruption of Cys 85 -Cys 391 will be instrumental for the emergence of such an aqueous O 2 channel. A detailed study on the reductive activation of Ero1p has also indicated that a subfraction of the long-range disulfide is resolved prior to the catalysis of substrate oxidation (27) .
Mechanisms of selection of specific sulfhydryl substrates
Among the total of *20 PDI-like proteins in humans (5), PDI itself has been shown to be the major substrate for Ero1-mediated oxidation. Numerous cues in favor of this view exist including data from both cell culture and in vitro assays (6, 7, 29, 53) . Ero1a recognizes PDI by a lock-and-key principle irrespective of whether or not the redox-active cysteines are present in PDI (29, 41) . Thus, initial binding prior to the formation of a catalytic mixed disulfide occurs through noncovalent interactions. It has been conclusively demonstrated that these interactions are of hydrophobic nature (29) . They involve a protruding b-hairpin in Ero1a, which contains a critical tryptophan residue at its very tip (Trp   272   ) , and a hydrophobic cleft in the substrate-binding domain of PDI (36) . Even though experimental data were exclusively generated with Ero1a, both the hairpin structure and the crucial tryptophan are present in Ero1b as well (Fig. 4) . Accordingly, the principle of substrate recognition is probably conserved among the mammalian isoforms. In addition, as hinted by in silico complex modeling (36) , this mode of interaction presumably facilitates the specific thiol-disulfide exchange between the Cterminal active-site domain of PDI and the shuttle disulfide in Ero1a (7, 9, 10, 15, 52). In contrast, Ero1p harbors no tryptophan-containing b-hairpin (25) and preferentially oxidizes the N-terminal active-site domain of yeast PDI (51) .
As opposed to the bona fide substrate PDI, its homolog ERp44 can efficiently bind to Ero1a even in the absence of the b-hairpin (36). Further, equal amounts of ERp44-Ero1a mixed disulfides are detected with all single-cysteine mutants of Ero1a (12), indicating that ERp44 can attack at least one disulfide other than the shuttle disulfide with its active-site cysteine. Besides these, also other PDI-family members-although inferior substrates for oxidation (29, 53) -form mixed disulfides with Ero1a and Ero1b within cells under steady-state conditions (7, 30, 46) . As pointed out for PDI (7), these complexes most likely involve an oxidized (noncatalytic) form of Ero1a. In addition, they are not strictly dependent on the presence of an intact shuttle disulfide (7, 12) so that they might be formed in analogy to the ERp44-Ero1a interaction. The physiological roles of these covalent complexes are currently unclear.
Ero1a and Ero1b: Functional substitutes or brothers in arms?
While the above sections have highlighted many shared catalytic characteristics between Ero1a and Ero1b, the two homologs have also diverged in a number of features. For instance, the transcriptional regulation of ERO1L and ERO1LB is different, which undoubtedly contributes to the distinct expression profiles in human tissues (42) (Fig. 5) . The high Ero1b levels in insulin-producing b-cells of the pancreas are maintained by the key pancreatic transcription factor 1112 RAMMING AND APPENZELLER-HERZOG PDX1 (31). The importance of Ero1b in these cells is highlighted by the finding that the oxidative maturation of proinsulin is delayed in pancreatic islets from ERO1LB mutant mice, which manifests in a diabetic phenotype (55) . Intriguingly, this phenotype is neither complemented by a compensatory increase in Ero1a levels nor exacerbated by additional mutation of ERO1L, which argues against redundancy of Ero1 isoforms in the endocrine pancreas of mice (55) . ERO1LB is also a target of the ER-stress-responsive transcription factor ATF6a (1) that is preferentially activated under reducing ER conditions (39) . ERO1L, on the other hand, is a transcriptional target of HIF1a that is upregulated in response to hypoxia or hypoglycemia (23, 37) . Indeed, Ero1a is instrumental in counteracting ER hypo-oxidation brought about by hypoxic treatment of cells (16) . In addition, the expression of ERO1L is enhanced during adipogenesis, which depends on the nuclear hormone receptor peroxisome proliferator-activated receptor gamma (PPARc) (45) . Finally, Ero1a is induced during a late stage of ER stress signaling through the binding of C/EBP homologous protein (CHOP; also known as Gadd153) to its promotor (34) (see below).
Ectopic expression of Ero1b-in contrast to Ero1a that has no discernible effect-moderately increases the oxidation of ER oxidoreductases and glutathione (6) . This is likely owing to the relative lability of the regulatory disulfide bonds in Ero1b, since mutation of Cys 100 and Cys 130 in Ero1b does not activate the purified enzyme to the same extent as the equivalent mutations in Ero1a (53) . Further, wild-type Ero1b shows higher rates of oxygen consumption during in vitro substrate oxidation compared with Ero1a (53) . At the same time, however, the initial slope of glutathione re-oxidation after complete chemical reduction is less pronounced in Ero1b-than in Ero1a-overexpressing cells (7) . Thus, the catalytic turnover rates of Ero1a and Ero1b differ in a context-dependent manner.
Can these disparities be explained at the molecular level? One of the two intercalating amino acids between the inner active-site cysteines in Ero1a and Ero1b is different (Fig. 4) . When mutated to the Ero1b active-site sequence, the catalytic turnover number of Ero1a increases (53) . Moreover, Ero1b harbors an additional cysteine at position 262 (Fig. 4) , which has been proposed to form a unique type of regulatory disulfide together with Cys 100 (53) . However, as predictable by homology to Ero1a, Cys 262 is located at the end of one of the 
ERO1 FAMILY ENZYMES IN MAMMALS
four core a-helices and immediately upstream of the PDIinteracting b-hairpin loop (Fig. 4) . We therefore consider it unlikely that this region adopts a fundamentally different conformation in Ero1b. In a structural homology model, the side chain of Cys 262 is located *30 Å away from Cys 100 and buried in the structure (data not shown). Finally, Ero1b harbors three unique N-glycosylation sites in the peptide surrounding Cys 130 (Fig. 4 ). In the model, the glycosylated asparagines are solvent exposed and positioned between the PDI-binding site and the shuttle disulfide (data not shown), raising the possibility that substrate recruitment might be modulated by the presence of bulky oligosaccharides. Overall, Ero1b-basally expressed at low levels ( Fig. 5) and an early target of the ER stress response (1)-represents an effective stress oxidase that can counteract ER hypo-oxidation. Ero1a, on the other hand, likely fulfills a tightly regulated housekeeping function with regard to disulfide generation.
Whether and to what extent the two isoforms functionally and/or physically interact in tissues where they are coexpressed remains to be examined.
Ero1a Is Critical for ER-Stress-Induced Apoptosis
Besides the regulated production of disulfides, Ero1a has additional roles. A major fraction of Ero1a molecules localizes to so-called mitochondria-associated membranes (MAMs), a subdomain of the ER that is tethered to mitochondria (3, 24) . When activated by exogenous reductants or under hypoxic conditions, Ero1a relocates to the bulk of the ER (24), suggesting that its function at the MAM might be independent of its activity as an oxidase. The excitable calcium channels of the inositol 1,4,5-trisphosphate receptor (IP 3 R) family are also enriched in MAMs, and IP 3 R-facilitated calcium shuttling to cytosol and mitochondria is a critical branch of apoptotic cell death signaling during severe ER stress (17) . One of the switches that positively regulate such calcium flow is Ero1a (32), which is induced by the ER stress-dependent, apoptogenic transcription factor CHOP (34) . Since the channeling activity of IP 3 R subtype 1 is impeded by reversible binding of ERp44 (28), elevated levels of Ero1a-a preferred ligand of ERp44 (2, 36)-likely activate IP 3 R1 during ER stress by sequestering ERp44 (in analogy to the mechanism described in the next section). Conversely and similar to the knockdown of IP 3 R1, silencing of Ero1a in macrophages inhibits ER-stressinduced apoptosis by lowering ER calcium release (32) . Recently, knockdown of Ero1a in HeLa cells has been demonstrated to predominantly hamper the accumulation of calcium in mitochondria upon stimulation of IP 3 Rs (and only marginally in the cytosol), which is in agreement with the enrichment of Ero1a in MAMs (3).
An alternative, although less plausible possibility is that Ero1a does not enhance IP 3 R1 activity by lowering the availability of ERp44 but by hyperoxidizing the ER. The inhibitory association with ERp44 depends on two reduced cysteinyl thiols in IP 3 R1 (28), the oxidation of which upon ER stress could consequently lead to channel activation. In   FIG. 5 . Tissue-specific mRNA levels of human ERO1L and ERO1LB. Expression levels of ERO1L and ERO1LB mRNAs (encoding Ero1a and Ero1b, respectively) in a range of human tissues shown as signal intensity on Affymetrix Human Genome U133A array (probe sets: 218498_s_at for ERO1L and 220012_at for ERO1LB). The figure was generated with all available datasets using the Genevestigator software (www.genevestigator.com/gv). The signal intensity on the abscissa is expressed on an arbitrary, logarithmic scale. The abundance of ERO1L mRNA is overall higher than that of ERO1LB. ERO1LB expression peaks in the stomach, the testis, and the pancreatic islets of Langerhans (highlighted with dark gray boxes). In contrast, elevated levels of ERO1L mRNA can be detected especially in tonsils, oral region, and oesophagus (highlighted with light gray boxes).
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RAMMING AND APPENZELLER-HERZOG potential support of this, antioxidant treatment mimicked the inhibitory effect of Ero1a knockdown on ER calcium release (32) . However, as the CHOP-Ero1a-IP 3 R1 signaling pathway induces NADPH oxidase 2-derived reactive oxygen species (ROS), which in turn further amplify CHOP (33), the application of antioxidants did not necessarily exert its effect by counteracting Ero1a activity. Moreover, given the tight regulatory mechanisms that prevent excessive disulfide and H 2 O 2 synthesis by Ero1a (see above), its increased expression does not per se hyperoxidize the ER (6, 7). The probably minor contribution of Ero1-derived ROS to ER-stressinduced cell death has recently been evaluated in detail elsewhere (4) .
Role of Ero1a in ERp44-Mediated ER Retention/Retrieval
Apart from their involvement in calcium signaling, Ero1a and ERp44 orchestrate the secretion of diverse disulfidelinked dimers and higher order oligomers by the reversible formation of mixed-disulfide ERp44-protein adducts (Fig. 6 ).
ERp44 binds to substrates via its nonclassical CXXS active-site motif (2), which lacks a resolving cysteine and therefore renders these intermolecular disulfide adducts longer-lived than typical catalytic complexes. Moreover, despite its C-terminal ER retrieval signal ERp44 is atypically enriched in the ERGolgi intermediate compartment (ERGIC)/cis-Golgi (35, 54) , which favors a model in which ERp44 retrieves substrates from ERGIC/cis-Golgi to ER.
What is the role of Ero1a in the intracellular retention of secretory proteins? Increased expression of Ero1a displaces ERp44 from most of its endogenous substrates (2), indicating it to be a preferred mixed-disulfide ligand of ERp44. Accordingly, the secretion of ERp44 retention substrates such as IgM (2), the adipose-derived hormone adiponectin (54) , or sulfatase modifying factor 1 (SUMF1; also known as formylglycine-generating enzyme) (19, 35) is enhanced upon overexpression of Ero1a (Fig. 6 ). In the case of adipocytes, endogenous induction of Ero1a by PPARc agonists is physiologically relevant during differentiation and stimulation (45, 54) . Although speculative, vascular endothelial growth factor Interplay between Ero1a and ERp44 governs the secretion of various disulfide-linked dimers/oligomers. ERp44 mediates ER retention or retrieval from ERGIC/cis-Golgi of various immature monomers destined for dimerization/oligomerization and secretion. In this process, substrate binding by ERp44 is stabilized by formation of an interchain disulfide bond involving Cys 29 in ERp44. Upon exogenous overexpression or endogenous induction, Ero1a can-most likely by a competitive mechanism-displace these substrates from ERp44, thus promoting their maturation into disulfide-linked protein complexes and subsequent secretion. In addition to the known ERp44 substrates IgM, SUMF1, and adiponectin, VEGF displays similar properties, rendering it a potential ERp44 substrate (as indicated by the question marks). While the cysteine residues responsible for ERp44-association and oligomerization have been identified in the substrate proteins, it is still unclear, whether a specific cysteine in Ero1a is involved or Ero1a acts as a multivalent mixed-disulfide partner of ERp44 (question mark). The graphical depiction of the structure of the mature IgM pentamer (that contains two heavy and two light chains per monomer) is simplified, and the existence of alternative oligomers (involving a J-chain) is neglected. The Nterminal domains of the adiponectin trimer form a collagen-like triple helix that can dimerize (or multimerize, not shown) through Cys 36 -mediated interchain disulfide-bond formation. Regarding SUMF1, it is important to point out that the drawn mechanism of Ero1a-induced secretion only applies to overexpressed protein (endogenous SUMF1 is an ER-resident enzyme). Cysteine residues are represented only by their sulfur atoms, S; numbers, where indicated, show the position of the cysteine in the human amino acid sequence. ERGIC, ER-Golgi intermediate compartment; IgM, immunoglobulin M; SUMF1, sulfatase modifying factor 1; VEGF, vascular endothelial growth factor.
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(VEGF) might also add to the list of ERp44 substrates, as its secretion, which is prominent in hypoxic tumors, is positively regulated by Ero1a (37) (Fig. 6) .
All secretory ERp44 substrates identified so far (and VEGF) undergo cysteine-dependent dimerization/oligomerization to be secreted. The cysteines engaged in this process have, in case of retention, previously been linked to ERp44 (Fig. 6) , which is consistent with the concept that ERp44 traps incompletely assembled subunits. Although this concept is commonly referred to as ''thiol-mediated retention,'' it is still unclear how these trapping interactions are formed. As ERp44 comprises a single-cysteine active site, the oxidizing equivalents to join two thiol groups would either have to be contributed by the binding partner (e.g., through an intramolecular disulfide or glutathionylation) or by ERp44 itself. The latter possibility could involve a disulfide-linked homodimer or a heterodimer composed of Ero1a and ERp44. However, as detailed above, abundant Ero1a-ERp44 complexes rather inhibit than promote ''thiol-mediated retention.''
Conclusions and Perspectives
Ero1 enzymes are an integral part in our understanding of redox maintenance in the ER. The two mammalian isoforms, which differ from the yeast enzyme in a number of aspects, fulfill similar roles in regulated disulfide production, but also display distinctive features. While recent work has begun to link these features to isoform-specific in vivo functions, there is certainly more room for discovery regarding the physiological roles of Ero1a and Ero1b. An eminent question for the future is how redundant these roles are in mammals. Given the viability of ERO1L/ERO1LB gene trap mice that still harbor detectable levels of the stress oxidase Ero1b (55), it is possible that Ero1b can largely substitute for Ero1a deficiency. Motivated by the finding that cardiomyocytes show decreased excitability due to lowered calcium transients in ERO1L mutant mice (16), however, it will be important to more closely look at, for example, ER-stress-induced apoptosis or the secretion of ERp44 substrates in these mice. Moreover, the question whether ERO1L/ERO1LB knockout mice are also viable remains to be answered.
Since the reduction of O 2 by Ero1 oxidases produces cytotoxic H 2 O 2 in the ER, the function of ER-resident H 2 O 2 -degrading peroxidases and their crosstalk with the PDI family are likely to be fundamental (4, 13) . For instance, the activity of peroxiredoxin IV can produce disulfides and channel them into oxidative folding (56) . As for Ero1-derived H 2 O 2 , it will be most interesting to carry out loss-of-function analyses with two other PDI peroxidases, GPx7 and GPx8, which physically interact with Ero1a (40) .
Many additional features of mammalian Ero1 enzymes still require further investigation. The functional significance of covalent Ero1 dimerization (18) that apparently involves Cys 166 in Ero1a (29) is completely obscure. Likewise, the molecular basis of membrane association of Ero1a is not known, and it remains to be clarified whether its ER retention/MAM localization is mostly mediated by interaction with the ER membrane (14, 42) or with ERp44 and other PDI family members (41) . In addition, the conservation among metazoans of the N-terminal segment including two disulfides in Ero1a (but not Ero1b, Fig. 3 ) suggests some as yet enigmatic function for this stretch of amino acids. It will also be instrumental to molecularly describe the mode(s) of interaction between Ero1a and ERp44 including the cysteine connectivities and subcellular localization of the complex (ER, ERGIC, or MAM) and compare it to the complex involving PDI (36) . Since the catalytic Ero1a-PDI interaction plays a critical role during the PDI-assisted translocation of the cholera toxin A1 subunit from the ER to the cytosol (38) , it also remains to be explored, if endogenous ER-associated degradation substrates require this interplay. Further, the mechanism of redox-driven activation of Ero1a/b remains to be elucidated, which-in conjunction with the aforementionedwill set the stage for more exciting Ero1 news in the future.
